Pharmafile Logo
Pharmafocus logo
Advanced Search

Exubera

Showing 5 posts of 5 posts found.

manufacturing_compounding

Mannkind’s inhaled insulin Afrezza edges closer to market

August 19, 2013
Research and Development, Sales and Marketing Afrezza, Exubera, Mannkind, inhaled insulin

News

NantWorks to invest $85.5m in former Pfizer plant

January 16, 2012
Manufacturing and Production Exubera, Nantworks, Pfizer

A former Pfizer manufacturing facility in Indiana, US, looks set for a new lease of life after technology company NantWorks …

News

Pfizer abandons Exubera

October 19, 2007
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …

News

Exubera approval limited to needle-phobic patients

January 26, 2007
Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin

 Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …

News

Pfizer to go it alone with Exubera

January 16, 2006
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

 Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024